検死で決定された動脈硬化症の流行とリスク因子,アメリカ軍人の間で,2001年~2011年
Bryant J Webber1, Peter G Seguin, Daniel G Burnett
1Uniformed Services University of the Health Sciences, PMB, 4301 Jones Bridge Rd, Room A1040A, Bethesda, MD 20814, USA. bryant.webber@usuhs.edu
JAMA
|December 27, 2012
まとめ
冠動脈動脈硬化症は,米国の若い軍人の8.5%で発見され,年齢とともに罹患率が増加し,失血症,高血圧,肥満などの心血管リスク要因が増加しました.
科学分野:
- 心血管病理学 心血管病理学
- 軍事医学は軍事医学でした.
- エピデミオロジー エピデミオロジー
背景:
- 冠動脈の動脈硬化変化は,若年成人期に現れ,不全性心臓病の臨床的徴候に先行する可能性があります.
- 朝鮮戦争とベトナム戦争の犠牲者に関する以前の研究では,動脈硬化症の早期発症が示された.
研究 の 目的:
- 米国軍における冠動脈および大動脈動脈硬化症の現在の流行を決定する.
- 人口統計や病歴の要因に基づいて,動脈硬化症の罹患率を分析する.
主な方法:
- 横断的な研究では,永続的な自由とイラクの自由/新夜明け作戦 (2001年10月~2011年8月) で死亡した米軍兵士の心臓血管解剖報告を分析した.
- 動脈硬化症の重症度は,最小,中程度,または重症に分類されました.
- 心血管疾患の危険因子に関する様々な人口統計的特徴と診断において,その有病率を調査した.
主要な成果:
- この研究には3832人の軍人 (平均年齢25.9歳,男性98.3%) が参加した.
- 冠動脈動脈硬化症は8.5%の症例で,重症は2.3%の症例でした.
- 動脈硬化症の罹患率は,年配の軍人および脂質不全症,高血圧,または肥満の診断を受けた者において高かった.
結論:
- 動脈硬化症は,最近の紛争で死亡した若い米軍兵士の有意な割合に存在しています.
- 罹患率は,年齢増加と心血管疾患のリスク要因の存在に関連しており,早期介入の必要性を強調しています.
関連する概念動画
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
